NEW!

More documents

Recommendations

Info

Thursday, April 21 Integrated Neuroscience Session 1:00 p.m.–5:30 p.m. Integrated Neuroscience Session I13 S Sports-related Concussion: Vision and Vestibular Insights This program is offered in partnership with the North American Neuro-ophthalmology Society and the AAN Neuro-ophthalmology/Neuro-otology Section. Coordinators: Steven Galetta, MD, FAAN, and Laura J. Balcer, MD, MSECE, FAAN Program Description: Sports-related concussion is recognized as a potential cause of both short- and long-term neurologic sequelae. Concussion is associated with many visual and vestibular signs and symptoms. Performance measures that capture these aspects of neurologic function enhance the detection of concussion on the sidelines. Through a combination of didactic, data-driven talks and platform and poster presentations of the latest research findings, this program will highlight the exciting and timely intersection of neuro-ophthalmology, neuro-otology, and sports neurology. Upon Completion: Participants should be able to identify features of the visual and vestibular pathways that render them particularly vulnerable to concussion, and to articulate the importance, feasibility, and methodologies for incorporating vision- and vestibular-based assessments into sideline testing and concussion management. Importantly, participants will also understand the global nature of the concussion epidemic and be familiar with cutting-edge research findings that support the vision and vestibular systems as targets for diagnosis, management, and emerging therapies. Part I 1:00 p.m.–2:45 p.m. 1:00 p.m.–1:05 p.m. Introduction Laura J. Balcer, MD, MSCE, FAAN, and Steven Galetta, MD, FAAN 1:05 p.m.–1:35 p.m. Invited Speaker The NCAA Experience: What is Our Vision for Concussion? Brian W. Hainline, MD, FAAN 1:35 p.m.–1:40 p.m. I13.001 Data Blitz Agreement of the Spiral-Bound and Computerized Tablet Versions of the King- Devick Test of Rapid Number Naming for Sports Related Concussion —Jenelle Raynowska, Lisena Hasanaj, Arlene Silverio, Janet Rucker, Steven Galetta, Laura Balcer 1:40 p.m.–1:45 p.m. I13.002 Data Blitz Visual Performance of Non-Native Versus Native English Speakers on a Sideline Concussion Screen: An Objective Look at Eye Movement Recordings —Katharine Dempsey, Joel Birkemeier, Todd Hudson, Weiwei Dai, Ivan Selesnick, Lisena Hasanaj, Laura Balcer, Steven Galetta, Janet Rucker, John-Ross Rizzo 1:45 p.m.–1:55 p.m. Audience Q&A 1:55 p.m.–2:25 p.m. Invited Speaker Concussion: The Anatomy and Physiology of Vision Testing Steven Galetta, MD, FAAN, New York, NY 2:25 p.m.–2:30 p.m. I13.003 Data Blitz Yield of the Clinical Neuro-Ophthalmologic Examination in Patients with Concussion —Katharine Dempsey, Joel Birkemeier, John-Ross Rizzo, Lisena Hasanaj, Laura Balcer, Steven Galetta, Janet Rucker 2:30 p.m.–2:35 p.m. I13.004 Data Blitz Evaluating Concussion Recovery Through Oculomotor Testing —Melissa DiFabio, Jessie Oldham, Ryan DeWolf, Thomas Kaminski, Thomas Buckley 2:35 p.m.–2:45 p.m. Audience Q&A Guided Poster Rounds I13.001 Agreement of the Spiral-Bound and Computerized Tablet Versions of the King-Devick Test of Rapid Number Naming for Sports Related Concussion — Jenelle Raynowska, Lisena Hasanaj, Arlene Silverio, Janet Rucker, Steven Galetta, Laura Balcer I13.002 Visual Performance of Non- Native Versus Native English Speakers on a Sideline Concussion Screen: An Objective Look at Eye Movement Recordings —Katharine Dempsey, Joel Birkemeier, Todd Hudson, Weiwei Dai, Ivan Selesnick, Lisena Hasanaj, Laura Balcer, Steven Galetta, Janet Rucker, John-Ross Rizzo I13.003 Yield of the Clinical Neuro- Ophthalmologic Examination in Patients with Concussion —Katharine Dempsey, Joel Birkemeier, John-Ross Rizzo, Lisena Hasanaj, Laura Balcer, Steven Galetta, Janet Rucker 2:45 p.m.–3:15 p.m. I13.004 Evaluating Concussion Recovery Through Oculomotor Testing — Melissa DiFabio, Jessie Oldham, Ryan DeWolf, Thomas Kaminski, Thomas Buckley I13.005 The Ocular Motor Underpinnings of Rapid Number-Naming As a Sideline Performance Measure for Concussion —Joel Birkemeier, Todd Hudson, John-Ross Rizzo, Weiwei Dai, Ivan Selesnick, Lisena Hasanaj, Laura Balcer, Steven Galetta, Janet Rucker I13.006 Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort —Lisena Hasanaj, Nikki Webb, Joel Birkemeier, Liliana Serrano, Rachel Nolan, Jenelle Raynowska, Luiz Souza-Filho, Todd Hudson, John-Ross Rizzo, WeiWei Dai, Janet Rucker, Steven Galetta, Laura Balcer I13.007 Initial Validation of a Novel Neuro-Ophthalmologic Set-Shifting Saccade Task —Adam Simon, Stephen Martino, David Devilbiss I13.008 No Changes in Postural Control or Near-Point Convergence Following an Acute Bout of Soccer Heading —Jaclyn Caccese, Thomas Buckley, Thomas Kaminski I13.009 To Study Risk of Seizures After Mild Traumatic Brain Injury in General Population —Suresh Kumar, Pooja Shah, Martin Bringham I13.010 First Results from a 3 Year Study in Sports Concussion In Varsity Athletes at Lehigh University Using a Novel Biosensor Based Assessment Platform —Adam Simon, David Devilbiss Part II I13.011 Multivariate Models of Biosensor Data to Actively Assess Sports Concussion and Mild Traumatic Brain Injury —Adam Simon, David Devilbiss I13.012 Changes in Balance Error Scoring System (BESS) Scores and Center-of-Pressure Following Concussion —Jaclyn Caccese, Thomas Buckley, Ryan DeWolf, Thomas Kaminski I13.013 Visual Tracking Eye Movement Characteristics in Concussion-Vulnerable Population and in Recovering Patients — Jessica Little, Jun Maruta, Stephanie Kolakowsky-Hayner, Jianliang Tong, Umesh Rajashekar, Ghajar Jamshid 3:15 p.m.–5:30 p.m. 3:15 p.m.–3:40 p.m. Invited Speaker Seeing a Balance: The Ocular Motor and Vestibular Examination Leonard Messner, OD, Chicago, IL 3:40 p.m.–3:45 p.m. I13.005 Data Blitz The Ocular Motor Underpinnings of Rapid Number-Naming As a Sideline Performance Measure for Concussion —Joel Birkemeier, Todd Hudson, John-Ross Rizzo, Weiwei Dai, Ivan Selesnick, Lisena Hasanaj, Laura Balcer, Steven Galetta, Janet Rucker 3:45 p.m.–3:50 p.m. I13.006 Data Blitz Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort —Lisena Hasanaj, Nikki Webb, Joel Birkemeier, Liliana Serrano, Rachel Nolan, Jenelle Raynowska, Luiz Souza- Filho, Todd Hudson, John-Ross Rizzo, WeiWei Dai, Janet Rucker, Steven Galetta, Laura Balcer 3:50 p.m.–4:00 p.m. Audience Q&A 4:00 p.m.–4:25 p.m. Invited Speaker Capturing Vision and Eye Movements: Where Science Meets the Sideline Janet C. Rucker, MD, New York, NY 4:25 p.m.–4:55 p.m. Invited Speaker Vestibular Dysfunction: Approaches and Updates Terry D. Fife, MD, FAAN 4:55 p.m.–5:00 p.m. I13.007 Data Blitz Initial Validation of a Novel Neuro-Ophthalmologic Set-Shifting Saccade Task — Adam Simon, Stephen Martino, David Devilbiss 5:00 p.m.–5:05 p.m. I13.008 Data Blitz No Changes in Postural Control or Near-Point Convergence Following an Acute Bout of Soccer Heading —Jaclyn Caccese, Thomas Buckley, Thomas Kaminski 5:05 p.m.–5:20 p.m. Audience Q&A 5:20 p.m.–5:30 p.m. Conclusion 146 2016 AAN Annual Meeting Abstract Listing
1:00 p.m.–5:30 p.m. Integrated Neuroscience Session I14 Practical Approaches to Narrowing the Epilepsy Treatment Gap Coordinators: Gretchen L. Birbeck, MD, MPH, DTMH, FAAN, and Steven C. Schachter, MD, FAAN Program Description: The Epilepsy Treatment Gap, meaning the proportion of people with epilepsy who warrant treatment but are not receiving it, provides critical but often over-simplified insights into epilepsy care access. The “treatment gap” alone does not detail who is left behind or why. Individual characteristics certainly influence care seeking behaviors and the capacity to successfully access care and adhere but the treatment gap is also heavily impacted by macroeconomic factors, sociocultural beliefs, health systems, human resources limitations, and regulatory barriers. Importantly, although the treatment gap metric is most often applied in resource-limited setting, in reality gaping holes in epilepsy care are universal and include delayed diagnoses and inequitable access to advanced diagnostics or subspecialty providers. This session will help attendees develop practical approaches to narrowing the treatment gap by delineating a conceptual framework, suggesting approaches to developing interventions/ activities and consideration of proxy outcomes that may be needed for intervention evaluations. Part I 1:00 p.m.–3:00 p.m. 1:00 p.m.–1:10 p.m. Introduction Steven C. Schachter, MD, FAAN, and Gretchen L. Birbeck, MD, MPH, DTMH, FAAN 1:10 p.m.–1:45 p.m. Invited Speaker Cost Considerations Across the SES Spectrum John Langfitt, PhD, Rochester, NY 1:45 p.m.–1:50 p.m. I14.001 Data Blitz Diagnostic Yield and Treatment Impact of Targeted Whole Exome Sequencing in Early Onset Epilepsy —Sarah Buerki, Eric Toyota, Ilaria Guella, Marna McKenzie, Dan Evans, Shelin Adam, Margot Van Allen, Cyrus Boelman, Gabriella Horvath, Clara Van Karnebeek, Patrice Eydoux, Linda Huh, Anita Datta, Kathy Selby, Aspasia Michoulas, Tanya Nelson, Mary Connolly, Matthew Farrer, Michelle Demos 1:50 p.m.–1:55 p.m. I14.002 Data Blitz Characteristics and Resource Utilization of U.S. Emergency Department Visits (2008-2011) for Patients with Epilepsy and Convulsions —Allison Petrilla, Xiaoping Ning, Erin Sullivan, Jane Osterhaus, Andrew Mosso, Gregory Gilmet 1:55 p.m.–2:05 p.m. Audience Q&A 2:05 p.m.–2:40 p.m. Invited Speaker Suboptimal Quality; A “Gap” by Any Other Name is a Still a “Gap” Anne T. Berg, PhD, Dekalb, IL 2:40 p.m.–2:45 p.m. I14.003 Data Blitz Medication Versus Management: Beyond Pills-to-Mouths Measures of Epilepsy Care —Erica McKenzie, Damber Nirola, Lhab Tshering, Sonam Deki, Bryan Patenaude, Sarah Clark, Sydney Cash, Ronald Thibert, Rodrigo Zepeda Garcia, Edward Leung, Alice Lam, Andrew Lim, Jo Mantia, Joseph Cohen, Andrew Cole, Farrah Mateen 2:45 p.m.–2:50 p.m. I14.004 Data Blitz Use of a Digital Self-Management Platform for Improving Access in Epilepsy Patients —John Hixson 2:50 p.m.–3:00 p.m. Audience Q&A Guided Poster Rounds I14.001 Diagnostic Yield and Treatment Impact of Targeted Whole Exome Sequencing in Early Onset Epilepsy — Sarah Buerki, Eric Toyota, Ilaria Guella, Marna McKenzie, Dan Evans, Shelin Adam, Margot Van Allen, Cyrus Boelman, Gabriella Horvath, Clara Van Karnebeek, Patrice Eydoux, Linda Huh, Anita Datta, Kathy Selby, Aspasia Michoulas, Tanya Nelson, Mary Connolly, Matthew Farrer, Michelle Demos I14.002 Characteristics and Resource Utilization of U.S. Emergency Department Visits (2008-2011) for Patients with Epilepsy and Convulsions —Allison Petrilla, Xiaoping Ning, Erin Sullivan, Jane Osterhaus, Andrew Mosso, Gregory Gilmet I14.003 Medication Versus Management: Beyond Pills-to-Mouths Measures of Epilepsy Care —Erica McKenzie, Damber Nirola, Lhab Tshering, Sonam Deki, Bryan Patenaude, Sarah Clark, Sydney Cash, Ronald Thibert, Rodrigo Zepeda Garcia, Edward Leung, Alice Lam, Andrew Lim, Jo Mantia, Joseph Cohen, Andrew Cole, Farrah Mateen 3:00 p.m.–3:30 p.m. I14.004 Use of a Digital Self- Management Platform for Improving Access in Epilepsy Patients —John Hixson I14.005 Prediction of Incident Epilepsy After First Seizure in Children with HIV/ AIDS in Botswana —David Bearden, Dennis Dlugos I14.006 Healthcare Resource Utilization Among Persons with Epilepsy Treated by Different Healthcare Providers —Sandra Helmers, Shaloo Gupta, Russell Knoth I14.007 Stigma Reduction Efforts: Evaluating a Multi-Faceted Intervention Aimed at Teachers in Zambia — Masharip Atadzhanov, Natalie Thornton, Elwyn Chomba, Edward Mbewe, Gretchen Birbeck I14.008 Epilepsy Prevalence, Treatment Gap, and Stigma in Western Kenya — Dilraj Sokhi, Monica Diaz, Anthony Ngugi, Tom Solomon, Eric Fevre, Ana-Claire Meyer I14.009 The Yield of EEG Studies in a Lower Income Country Epilepsy Referral Center —Janice Wong, Sydney Cash, Ronald Thibert, Esther Bui, Rodrigo Zepeda Garcia, Alice Lam, Edward Leung, Liesly Lee, Andrew Lim, Jo Mantia, Joseph Cohen, Erica McKenzie, Damber Nirola, Sonam Deki, Lhab Tshering, Tali Sorets, Sarah Clark, Bryan Patenaude, Andrew Cole, Farrah Mateen I14.010 Comparing Anti-Epileptic Drug Preferences Between Neurologists and Patients: Results from a National Survey and Discrete Choice Experiment —Alan Ettinger, Fulton Velez, John Carter I14.011 Factors Contributing to Diagnostic Delay in Psychogenic Non-Epileptic Spells —Jessie Grewal, Jacquelyne Cios Part II I14.012 Evaluation of the Prevalence of Pharmacogenetic Polymorphisms in Pediatric Neurology Patients with Whole Exome Sequencing —Shannon DiCarlo, Elizabeth Alter, M Brooke Bernhardt, Mindl Messinger, Angus Wilfong I14.013 The Impact of Comorbid HIV Infection on Epilepsy-Associated Stigma Among Zambian Adults —Masharip Atadzhanov, Melissa Elafros, Joseph Gardiner, Izukanji Sikazwe, Jason Okulicz, Nigel Paneth, Julius Mulenga, Alan Haworth, Elwyn Chomba, Edward Mbewe, Gretchen Birbeck\ 3:30 p.m.–5:30 p.m. 3:30 p.m.–4:05 p.m. Invited Speaker Practical Approaches to Narrowing the Gap: Considerations from a Resource Limited, Tropical Setting Gretchen L. Birbeck, MD, MPH, DTMH, FAAN, Rochester, NY 4:05 p.m.–4:10 p.m. I14.005 Data Blitz Prediction of Incident Epilepsy After First Seizure in Children with HIV/AIDS in Botswana —David Bearden, Dennis Dlugos 4:10 p.m.–4:15 p.m. I14.006 Data Blitz Healthcare Resource Utilization Among Persons with Epilepsy Treated by Different Healthcare Providers —Sandra Helmers, Shaloo Gupta, Russell Knoth 4:15 p.m.–4:25 p.m. Audience Q&A 4:25 p.m.–5:00 p.m. Invited Speaker Stigma, a Wedge in the Gap? Nathalie Jette, MD, MSc, FRCPC, Calgary, AB, Canada 5:00 p.m.–5:05 p.m. I14.007 Data Blitz Stigma Reduction Efforts: Evaluating a Multi-Faceted Intervention Aimed at Teachers in Zambia —Natalie Thornton, Elwyn Chomba, Masharip Atadzhanov, Edward Mbewe, Gretchen Birbeck 5:05 p.m.–5:10 p.m. I14.008 Data Blitz Epilepsy Prevalence, Treatment Gap, and Stigma in Western Kenya —Dilraj Sokhi, Monica Diaz, Anthony Ngugi, Tom Solomon, Eric Fevre, Ana-Claire Meyer 5:10 p.m.–5:20 p.m. Audience Q&A 5:20 p.m.–5:30 p.m. Conclusion Thu · April 21 Fast and easy registration · AAN.com/view/AM16 147
Page 1 and 2:
NEW! Dates • Format • Value SCI
Page 3 and 4:
See the value! 2015 Meeting Price 2
Page 5 and 6:
What’s Inside Table of Contents I
Page 7 and 8:
Meeting! INTRODUCTION See You in Va
Page 9 and 10:
Additional Information INTRODUCTION
Page 11 and 12:
OVERVIEWS Mon April 18 Tue April 19
Page 13 and 14:
Schedule Planning Forms Use the con
Page 15 and 16:
My Friday $ A registration fee is r
Page 17 and 18:
Hot Topics Plenary Session Friday,
Page 19 and 20:
$ A registration fee is required L
Page 21 and 22:
Meeting Schedule 6:30 a.m.-8:30 a.m
Page 23 and 24:
Poster Session Schedule and Floorpl
Page 25 and 26:
Meeting Schedule P1.029 Efficacy an
Page 27 and 28:
Presenters Stand by Posters 5:30 p.
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
New Faculty and Trainee Reception!
Page 37 and 38:
Meeting Schedule 11:30 a.m.-6:30 p.
Page 39 and 40:
Saturday, April 16 1:00 p.m.-3:00 p
Page 41 and 42:
Meeting Schedule 1:00 p.m.-5:30 p.m
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Sunday, April 17 Scientific Platfor
Page 61 and 62:
Page 63 and 64:
I5 1:00 p.m.-5:30 p.m. Integrated N
Page 65 and 66:
Opening Party Experience New Ways t
Page 67 and 68:
Page 69 and 70:
Don’t Forget to Visit the Exhibit
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
P3.391 The Quix Test: A 30 Second T
Page 81 and 82:
Annual Meeting App Now Available Th
Page 83 and 84:
Meeting Schedule 9:00 a.m.-11:30 a.
Page 85 and 86:
Page 87 and 88:
I8 1:00 p.m.-5:30 p.m. Integrated N
Page 89 and 90:
Industry Therapeutic Updates Indust
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98: Presenters Stand by Posters 5:30 p.
Page 103 and 104: Frontiers in Neuroscience Plenary S
Page 105 and 106: Meeting Schedule 1:00 p.m.-3:00 p.m
Page 109 and 110: $ A registration fee is required L
Page 113 and 114: Meeting Schedule 6:30 a.m.-8:30 a.m
Page 125 and 126: Clinical Trials Plenary Session Wed
Page 131 and 132: Scientific Platform Sessions Meetin
Page 133 and 134: My Thursday $ A registration fee is
Page 135 and 136: Meeting Schedule 6:30 a.m.-8:30 a.m
Page 145 and 146: Neurology Year in Review Plenary Se
Page 147: Meeting Schedule 1:00 p.m.-3:00 p.m
Page 151 and 152: New Date and Time: CLOSING PARTY HA
Page 159 and 160: Association of Indian Neurologists
Page 161 and 162: Potamkin Prize for Research in Pick
Page 163 and 164: Cool An AAN initiative to help buil
Page 165 and 166: Closing Party Happy Hour Thursday,
Page 167 and 168: Annual Meeting Attendee Pricing: Go
Page 169 and 170: Disclaimers/Disclosures Disclaimer
Page 171 and 172: Hotel Reservations Why Book a Hotel
Page 173 and 174: Sitka Sq Abbott St Ontario St Ontar
Page 175 and 176: Luggage Restrictions for carry-on b
Page 177 and 178: 68 th Annual Meeting Exhibitors as
Page 179 and 180: 68 th Annual Meeting Planning Meeti
Page 181 and 182: Jonathan S. Katz, MD Jori Fleisher,
Page 183 and 184: AAN Leadership University courses a
show all

NEW!

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?